US 9783595
Neutralizing GP41 antibodies and their use
granted A61KA61K2039/505A61K39/42
Quick answer
US patent 9783595 (Neutralizing GP41 antibodies and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K39/42, A61K45/06, A61K49/0004